What this feed covers
GovPing monitors FDA warning letters, novel drug approvals, drug shortage notices, ICH guideline updates, USP notices, EMA news, DEA scheduling decisions, and TGA/WHO standards. AgencyIQ charges six figures for similar coverage.
Who this is for
Regulatory affairs professionals, pharmacovigilance teams, and medical affairs groups at pharma companies and CROs who need to track FDA and EMA actions without expensive subscriptions.
Recent changes
Monday, March 16, 2026
FDA Mammography Standards Quality Act Requirements Comment Request
The FDA has submitted a proposed collection of information related to Mammography Quality Standards Act requirements to the Office of Management and Budget (OMB) for review. The agency is requesting public comments on this information collection, with a deadline of April 13, 2026.
FDA Variance Application from William Moore - Public Comment
The FDA is accepting public comments on a variance application submitted by William Moore. The comment period is open until March 13. This action pertains to a specific application for a variance.
FDA Variance Approval for North Bay Productions
The FDA has issued a variance approval letter to North Bay Productions. This document, originating from the CDRH, signifies an approval related to a specific variance request.
FDA Variance Application from Low Frequency Productions
The FDA is accepting comments on a variance application submitted by Low Frequency Productions. This application pertains to medical device regulations. The comment period for this application closed on March 13.
Sunday, March 15, 2026
Pure Vitamins LLC Recalls Honey Products Due to Undeclared Sildenafil and Tadalafil
Pure Vitamins and Natural Supplements, LLC is voluntarily recalling honey products marketed as sexual enhancement due to undeclared sildenafil and tadalafil. These undeclared ingredients can interact with prescription medications and cause dangerous drops in blood pressure.
ACA Benefit Parameters and Basic Health Program Correction Proposed Rule
The Department of Health and Human Services (HHS) is issuing a correction to a proposed rule concerning the Affordable Care Act (ACA) benefit parameters and the Basic Health Program. This correction addresses technical errors, specifically the omission of column headings in several tables within the original proposed rule published on February 11, 2026.
NIH Terminates Minority Biomedical Research Support Program
The Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), is repealing the regulation for the Minority Biomedical Research Support (MBRS) program. This action is effective September 25, 2025, and aligns with recent Supreme Court decisions and executive orders concerning discrimination and DEI programs.
NIH Delays Effective Date for Privacy Act Exemptions
The National Institutes of Health (NIH) has further delayed the effective date for a final rule concerning Privacy Act exemptions for its police records. The effective date is now May 5, 2025, extended from the previously scheduled March 21, 2025.
NIH Delays Effective Date for Privacy Act Rule
The National Institutes of Health (NIH) has delayed the effective date of a final rule concerning a new Privacy Act system of records. The rule, originally set to take effect on February 18, 2025, is now delayed until March 21, 2025, in accordance with a presidential memorandum.
NIH Privacy Act Implementation Final Rule
The National Institutes of Health (NIH) has published a final rule implementing exemptions for a new Privacy Act system of records, 'NIH Police Records.' This rule exempts certain law enforcement investigatory materials from specific Privacy Act requirements to protect ongoing investigations and sources.
Last 7 days
Most active sources
Browse Categories
Activity
Get daily alerts
Morning digest delivered to your inbox. Free.
Free. Unsubscribe anytime.
104 monitored sources
FR: Inspector General Office, Health and Human Services Department
FR: Agency for Toxic Substances and Disease Registry
Regs.gov: Occupational Safety and Health Administration
Regs.gov: Substance Abuse and Mental Health Services Administration
Regs.gov: Centers for Disease Control and Prevention
Regs.gov: Occupational Safety and Health Review Commission
Regs.gov: Health Resources and Services Administration
Regs.gov: Agency for Toxic Substances and Disease Registry
FR: Reagan-Udall Foundation for the Food and Drug Administration
FR: National Bipartisan Commission on Future of Medicare
Regs.gov: Agency for Healthcare Research and Quality
Regs.gov: Centers for Medicare and Medicaid Services
FR: Substance Abuse and Mental Health Services Administration
Regs.gov: Federal Mine Safety and Health Review Commission
Regs.gov: Uniformed Services University of the Health Sciences
FR: Uniformed Services University of the Health Sciences
Frequently asked questions
How often is this feed updated?
GovPing checks source pages multiple times daily. FDA warning letters and drug approvals typically appear within hours of publication.
Does this cover EMA and international regulators?
Yes. We monitor the EMA, ICH, WHO, TGA (Australia), and other international health authorities alongside FDA.
Is GovPing free?
Yes. GovPing is free. For custom monitoring, Changeflow starts at $29/mo.
How is this different from AgencyIQ?
AgencyIQ charges six figures for FDA intelligence. GovPing monitors the same source pages for free, with AI summaries and attention-level ratings.
Need to monitor something else?
GovPing covers the common sources. For niche pages specific to your team, add custom URL monitoring with Changeflow.
Get Pharma & Life Sciences alerts
Daily digest of pharma & life sciences regulatory changes. AI-summarized, no noise.
Free. Unsubscribe anytime.